HF
CIGL

HRT Financial’s Concorde International Group CIGL Stock Holding History

HRT Financial’s Portfolio CIGL Stock Details CIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,869
Closed -$159K – 3910
2025
Q2 		$159K Buy
+10,869
New +$67.5K ﹤0.01% 2123

Other funds holding CIGL

SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

HRT Financial's CIGL Position: Q3 2025 in Review

HRT Financial sold out of Concorde International Group (CIGL) in Q3 2025, closing a stake of 10,869 shares — an estimated $159K sold.

HRT Financial first reported a position in CIGL in Q2 2025 and held it in 1 quarter. The position peaked at $159K in Q2 2025. 8 funds tracked by Wall St. Rank hold CIGL as of Q3 2025.

  • HRT Financial reported no remaining Concorde International Group position as of Q3 2025 after selling out during the quarter.
  • HRT Financial sold 10,869 Concorde International Group shares in Q3 2025, an estimated $159K.
  • HRT Financial first reported a position in Concorde International Group in Q2 2025 and held it in 1 quarter.
  • HRT Financial's Concorde International Group position peaked at $159K in Q2 2025.
  • 8 funds tracked by Wall St. Rank held Concorde International Group as of Q3 2025.

Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.